Upregulation of the immune system in primary hypercholesterolaemia: Effect of atorvastatin therapy

Journal of Internal Medicine

Volumn 257, Issue 6, 2005, Pages 523-530

  Sampietro, T ^a   Bigazzi, F ^a,b   Rossi, G ^a   Dal Pino, B ^a   Puntoni, M R ^a   Sbrana, F ^b   Chella, E ^b   Bionda, A ^b  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Adhesion molecules; Atherosclerosis; Atorvastatin; Complement; Hypercholesterolaemia

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; INTERCELLULAR ADHESION MOLECULE 1; STATINE DERIVATIVE;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG MECHANISM; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; BIOLOGICAL MARKERS; COMPLEMENT C3; COMPLEMENT C4; CORONARY ARTERIOSCLEROSIS; FEMALE; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; IMMUNITY, CELLULAR; INTERCELLULAR ADHESION MOLECULE-1; LIPIDS; MALE; MIDDLE AGED; PYRROLES; UP-REGULATION;

EID: 20144365871     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2005.01488.x     Document Type: Article

References (29)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-26.
2. Fagiotto A, Ross R, Harker L. Studies of hypercholesterolemia in the non-human primate. I. Changes that lead to fatty streak formation. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis 1984; 4: 323-40.
3. Printseva OY, Peclo MM, Gown AM. Various cell types in human atherosclerotic lesions express ICAM. Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. Am J Pathol 1992; 140: 889-96.
4. Gearing AJ, Newman W, Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-12.
5. Miwa K, Igawa A, Inoue H. Soluble E-selectin. ICAM-1 and VCAM-1 levels in systemic and coronary circulation in patients with variant angina. Cardiovasc Res 1997; 36: 37-44.
6. Hwang SJ, Ballantyne CM, Sharrett AR et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. Circulation 1997; 96: 4219-25.
7. Kilgore KS, Shen JP, Miller BF, Ward PA, Warren JS. Enhancement by the complement membrane attack complex of tumor necrosis factor α induced endothelial cell expression of E selectin and ICAM-1. Immunology 1995; 155: 1434-41.
8. Vaporcyan AA, Mulligan MS, Warren JS. Up-regulation of lung vascular ICAM-1 in rats is complement dependent. J Immunol 1995; 155: 1442-9.
9. Niessen HW, Lagrand WK, Visser CA, Meijer CJ, Hack CE. Upregulation of ICAM-1 on cardiomyocytes in jeopardized human myocardium during infarction. Cardiovasc Res 1999; 41: 603-10.
10. Hollander W, Colombo MA, Kramsch DM, Kirkpatrick B. Soluble protein in the human atherosclerotic plaque. With spectral reference to immunoglobulins, C3 complement component, alpha 1 antitrypsin and alpha 2 macroglobulin. Atherosclerosis 1979; 34: 391-405.
11. Hansson GK, Holm J, Kral IG. Accumulation of IgG and complement factor C3 in human arterial endothelium and atherosclerotic lesions. Acta Pathol Microbiol Immunol Scand A 1984; 92: 429-35.
12. Niculescu F, Hugo F, Rus HG, Vlaicu R, Bhakdi S. Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic plaques. Clin Exp Immunol 1987; 69: 477-83.
13. Seifert PS, Hugo F, Tranum J, Zahringer U, Muhly M, Bhakdi S. Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions. J Exp Med 1990; 172: 547-57.
14. Kume N, Cybulsky MI, Gimbrone MA. Lysophosphatidylcholine, a component of atherogenetic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992; 90: 1138-44.
15. Yokote K, Morisaki N, Zenibayashi M. The phospholipase-A2 reaction leads to increased monocyte adhesion of endothelial cells via the expression of adhesion molecules. Eur J Biochem 1993; 217: 723-29.
16. Sampietro T, Tuoni M, Ferdeghini M et al. Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia. Circulation 1997; 96: 1381-5.
17. Sampietro T, Bigazzi F, Dal Pino B et al. Upregulation of C3, C4, and soluble intercellular adhesion molecule-1 co-expresses with high sensitivity C reactive protein in familial hypoalphalipoproteinemia: further evidence of inflammatory activation. Heart 2004; 90: 1438-42.
18. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-95.
19. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
20. Moreno L, Sarria A, Lazaro A et al. Serum C4 concentration a risk of atherosclerosis. BMJ 1994; 309: 1087.
21. Muscari A, Bozzoli C, Puddu GM et al. Association of serum C3 levels with the risk of myocardial infarction. Am J Med 1995; 98: 357-64.
22. Price DT, Loscalzo J. Cellular adhesion molecules and atherogenesis. Am J Med 1999; 107: 85-97.
23. Hackman A, Abe Y, Insull W et al. Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 1996; 93: 1334-8.
24. Levine GN, Keaney JF, Vita JA. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanism. N Engl J Med 1995; 332: 512-21.
25. Vaughan CJ, Murphy MB, Buckley BM. Statins do more than just lower cholesterol. Lancet 1996; 348: 1079-82.
26. Maron DJ, Fazio S, Linton MR. Current perspective on statins. Circulation 2000; 101: 207-13.
27. Bonetti PO, Lerman LO, Napoli C, Lerman A. Statin effects beyond lipid lowering are they clinically relevant? Eur Heart J 2003; 24: 225-48.
28. Seifert PS, Kazatchkine MD. The complement system in atherosclerosis. Atherosclerosis 1988; 73: 91-104.
29. Kilgore KS, Friedrichs OS, Homeister JV, Lucchesi BR. The complement system in myocardial ischemia/reperfusion injury. Cardiovasc Res 1994; 28: 437-44.